Application of pegylated retinoic acid and self-assembly micelle thereof in drug delivery

A technology of pegylated retinoic acid and retinoic acid is applied in the directions of drug combinations, medical preparations without active ingredients, medical preparations containing active ingredients, etc., and can solve the problems of no literature report on the absorption of oral nanoparticles, etc., Achieve the effect of prolonging the half-life of the drug, simple preparation and small particle size

Active Publication Date: 2015-03-11
SHENYANG PHARMA UNIVERSITY
View PDF2 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, little literature has been reported on the effect of the hydration layer of PEG chain length on the absorption of orally administered nanoparticles.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of pegylated retinoic acid and self-assembly micelle thereof in drug delivery
  • Application of pegylated retinoic acid and self-assembly micelle thereof in drug delivery
  • Application of pegylated retinoic acid and self-assembly micelle thereof in drug delivery

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0041] Preparation of retinoic acid prodrug blocks with different PEG chain lengths.

[0042] All-trans retinoic acid (ATRA) was dissolved in a small amount of dichloromethane in 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC) and 4-dimethylamino Under the catalysis of pyridine (DMAP), keep dark ice bath for 0.5-2h, then mix with polyethylene glycol (PEG) with different chain lengths at 30-40℃N 2 React for 10-12 hours under protection, and obtain a yellow oily pegylated retinoic acid amphiphilic prodrug through separation and purification. The reaction formula is as follows:

[0043]

Embodiment 2

[0045] The mPEG in the reaction formula can be mPEG 500 , mPEG 1000 , mPEG 2000 and mPEG 5000 That is, the selected polyethylene glycol has a molecular weight of 500, 1000, 2000 or 5000. The polyethylene glycol of the present invention is one end methylated modified polyethylene glycol, but it is not limited to the above four substances.

[0046] Determination by NMR 1 HNMR hydrogen spectrum to determine the structure of the block copolymer, the selected solvent is CHCl 3 , the result is as Figure 2 to Figure 5. The mass spectrum of ATRA-PEG500, the proton peak is from 1.1 to 2.3ppm, 5.8 to 7.1ppm is the characteristic peak of retinoic acid, the proton peak between 3.52-3.75ppm is H in PEG, and the proton peak at 3.37-3.38ppm is PEG The terminal methyl group (-CH 3 ) characteristic peaks, that is, mPEG proton peaks from 3.3 to 3.8ppm, and the new peak (a) about 4.2ppm belongs to methylene ( figure 2 ) near the ester bond.

Embodiment 3

[0048] Adopt infrared spectrum to determine the structure of block copolymer in embodiment 2, select KBr to be blank auxiliary material for use, the result is as follows Figure 6 to Figure 9 . ATRA-PEG500, at 3444cm -1 The broad absorption peak of hydroxyl group disappears and a new peak is about 1707cm -1 The emerging peak position is due to the conversion of the carboxy-hydroxyl group of ATRA to the ester bond in ATRA-PEG500, these results indicate the formation of PEGylated retinoic acid.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
particle diameteraaaaaaaaaa
Login to view more

Abstract

The invention relates to application of amphipathic pegylated retinoic acid and a self-assembly micelle thereof in drug delivery. An amphipathic prodrug block takes polyethylene glycol as a hydrophilic end and is bonded with hydrophobic retinoic acid through an ester bond, so that an AB type amphipathic prodrug block is obtained. The polymer has effects of potential treatment for leukemia and prolonging the half life of drug, has a higher drug loading rate, and effectively increases gastrointestinal mucosa permeability so as to increase the oral bioavailability. The pegylated prodrug is self-assembled to form the micelle in an aqueous medium, and the micelle can be used as a storage cavern of the indissolvable drug retinoic acid to slowly release retinoic acid. The micelle is good in safety, can be used for oral administration, and has a great market application prospect.

Description

technical field [0001] The invention belongs to the field of new excipients and new dosage forms of pharmaceutical preparations, and relates to the application of PEGylated retinoic acid and its self-assembled micelles in drug delivery, in particular to the amphiphilic prodrugs of polyethylene glycol retinoic acid with different chain lengths used as drug carriers in drug delivery. application in transit. Background technique [0002] Nanocarriers are widely used in targeted drug delivery systems because they can improve the efficacy of anticancer drugs and reduce drug side effects. PEGylated nanocarriers can show some unique advantages, such as prolonging the circulation time of nanoparticles; through EPR Effects Increase the accumulation of drugs in tumors; improve drug tolerance and so on. Among many carriers, PEGylated nanomicelles have attracted more attention due to their modifiable chemical structures and self-assembly into core-shell structures in aqueous solution. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K47/34A61K9/107A61K31/704A61P35/02
Inventor 孙进何仲贵李真宝韩晓鹏
Owner SHENYANG PHARMA UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap